Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Flexion Therapeutics Inc | flxn-10k_20171231.htm |
| EX-32.1 - EX-32.1 - Flexion Therapeutics Inc | flxn-ex321_12.htm |
| EX-31.1 - EX-31.1 - Flexion Therapeutics Inc | flxn-ex311_7.htm |
| EX-21.1 - EX-21.1 - Flexion Therapeutics Inc | flxn-ex211_8.htm |
| EX-10.13 - EX-10.13 - Flexion Therapeutics Inc | flxn-ex1013_348.htm |
| EX-10.12 - EX-10.12 - Flexion Therapeutics Inc | flxn-ex1012_347.htm |
| EX-10.11 - EX-10.11 - Flexion Therapeutics Inc | flxn-ex1011_346.htm |
| EX-10.6 - EX-10.6 - Flexion Therapeutics Inc | flxn-ex106_506.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-219099) and Form S‑8 (Nos. 333-193907, 333-202957, 333-210111, 333-216615 and 333-221373) of Flexion Therapeutics, Inc. of our report dated March 8, 2018 relating to the financial statements, which appears in this Form 10‑K.
|
/s/ PricewaterhouseCoopers LLP |
|
Boston, Massachusetts |
|
March 8, 2018 |